International Association of
Therapeutic Drug Monitoring and Clinical Toxicology
Fostering education, research and practice in TDM and CT

A History of IATMDCT Council Leadership

IATDMCT has been fortunate to have experienced such generous levels of expert leadership and guidance. To this end we would like to acknowledge those who stepped forward and lead us to where we are today.

Council Members 2013-2015

IATDMCT Council 2013-2015


2013 2015 Wallemacq Pres 150x200

IATDMCT President

Pierre Wallemacq
University of St. Luc, Brussels, Belgium

[+] View Bio

Dr Pierre Wallemacq, is Professor at the Université Catholique de Louvain, Medical school in Brussels, Belgium. He teaches clinical chemistry, toxicology and clinical pharmacokinetics, and is the vice president of the Biomedical Sciences School. He is one of the co-founders of the Louvain centre for Toxicology and Applied Pharmacology (LTAP) in the Medical School, and supervises several PhD theses and post-doc fellows. He is also head of Clinical Chemistry Department in the Cliniques universitaires St Luc, Brussels, in charge of the automated CoreLab platform as well as of the analytical biochemistry platform regrouping specific activities such as TDM, clinical toxicology, forensic toxicology, but also special chemistry and endocrinology (GC, HPLC, UPLC, LC-MSMS, GC-MS).

He started working in the field of TDM since 1982 with his PhD thesis on cyclosporine, and is author or co-author of more than 180 peer-reviewed manuscripts and nine textbook chapters. He has presented at more than 200 conferences on invitation. Most of his work was dedicated to immunosuppressive drugs, but he also published works in other clinical chemistry or TDM/TOX areas. Pierre Wallemacq is the past-president of the Royal Belgian Society of Clinical Chemistry (SRBCC-KBVKC), and is the current president of the Belgian and Luxemburg society of Toxicology (BLT). He is member of the Editorial Boards of several International Journals such as Therapeutic Drug Monitoring (TDM), Clinical Biochemistry (CLB), Clinical Chemistry and Laboratory Medicine (CCLM). Since July 2009, he serves as Associate Editor for Clinical Biochemistry. He received the IATDMCT C.E. Pippenger award in 2011 for outstanding contribution to Therapeutic drug Monitoring, and was nominated member of the Royal Belgian Academy of Medicine (ARMB) in 2012.


2013 2015 Langman PresElect 150x200

IATDMCT President-Elect

Loralie Langman 
Mayo Clinic, Rochester, MN, USA

[+] View Bio

Loralie Langman got her BSc in Laboratory Medicine and Pathology, CSMLS, and ASCP certifications at the University of Alberta. She completed her Ph.D. Laboratory Medicine and Pathology at the University of Alberta. She completed her Clinical Chemistry training at the University of Toronto, specializing in Forensic Toxicology and Molecular Genetics. She worked in Vancouver, British Columbia, at the Provincial Toxicology Centre and BC Biomedical Laboratories as a Forensic Toxicologist/Clinical Chemist. She is currently the Director, Toxicology and Drug Monitoring Laboratory, Mayo Clinic Rochester, MN and Associate Professor of Laboratory Med/Pathology, Mayo Clinic College of Medicine.

Dr. Langman was certified with the Canadian Academy of Clinical Biochemistry (CACB) and is the first individual to have achieved Diplomat status with the American Board of Clinical Chemistry (ABCC) in all three disciplines (Clinical Chemistry, Molecular Diagnostics, Toxicological Chemistry). She is also a Diplomat with the American Board of Forensic Toxicology.

Dr. Langman is a member of and serves on committees for several professional organizations including: The Society of Forensic Toxicologists (SOFT); the American Academy of Forensic Sciences (AAFS); the National Academy of Clinical Biochemistry (NACB); the Canadian Society of Clinical Chemists (CSCC); The International Association of Forensic Toxicologists (TIAFT), the American Association for Clinical Chemistry (AACC), the International Federation of Clinical Chemistry And Laboratory Medicine (IFCC) and IATDMCT.

She has over 47 peer reviewed publications, 12 book chapters, over 60 abstracts and over 100 presentations at National and International meetings. Her areas of expertise include: clinical toxicology; drugs of abuse (particularly amphetamine-type stimulants and cocaine); post-mortem toxicology; therapeutic drug management (particularly immunosuppressant drugs); and pharmacogenetics.

 


2013 2015 Marquet PastPres 150x200

IATDMCT Past President

Pierre Marquet
University of Limoges, Limoges, France

[+] View Bio

Pierre Marquet has been a Doctor of Medicine since 1986 and obtained a master in statistics and epidemiology followed by a PhD in physiology in 1992. After several years as an assistant professor at Limoges University Hospital, he became an associate professor of pharmacology in 1998 and since 2001, has been a full professor at the Faculty of Medicine of Limoges, France. He was presented with the Young Scientist Award of the French Society of Analytical Toxicology in 1995, the IATDMCT Young Investigator Award in 2001 and C.E. Pippenger Award in 2009. At the IATDMCT, he chaired the Standard of Laboratory Practice Committee from 2001-2007, was elected Secretary in 2007 and then President-elect in 2009.

Pierre Marquet is currently:

  • Director of the INSERM U850 research unit called "Pharmacology of immunosuppressive drugs in transplantation" 
    (INSERM is the French Institute of Medical and Health Research)
  • Head of the "Pharmacology, Toxicology and Pharmacovigilance" Department at the University Hospital of Limoges
  • Vice-President of the board of Directors of University Hospital of Limoges, in charge of research
  • Member of the council of the French Society of Pharmacology and Therapeutics (SFPT)
  • Coordinator of the "drugs and pharmacology" working group of the French-speaking Society of Transplantation (SFT)
  • Member of several scientific committees

Pierre Marquet conducts translational research on treatment personalization, mainly concerning immunosuppressants (IS) in organ transplantation, which covers: new analytical methodologies for IS; metabolic, pharmacogenetic and pharmacodynamic studies of the IS; investigation of early biomarkers; epidemiological studies and clinical trials in transplant patients; and application to routine treatment personalization in transplant recipients. He has published over 160 papers in peer-reviewed, international journals. He is the coordinator of the European research program "Biomarkers of Renal Graft Injuries" (BIOMARGIN, FP7 Health).


2013 2015 Tanigawara Secretary 150x200

IATDMCT Secretary

Yusuke Tanigawara 
Keio University, Tokyo, Japan

[+] View Bio

Professor Yusuke Tanigawara is Professor of Clinical Pharmacokinetics and Pharmacodynamics, School of Medicine, Keio University, Tokyo, Japan. He received his Ph. D. in pharmaceutical sciences from Kyoto University in 1983. His research interests include pharmacokinetics, pharmacodynamics and optimal dosing algorithms for personalized medicine. He has been studying clinical pharmacokinetics and pharmacodynamics mainly in oncology and infectious diseases. His modeling and simulation studies on population pharmacokinetics and pharmacodynamics were applied to new drug development as well as rational use for routine patient care. He also investigates multi-omics biomarkers such as genomics, proteomics and metabolomics as factors causing individual variation in drug response. He is distinguished as one of the "ISI Highly Cited Researchers."

  • 1978 BSc. Faculty of Pharmaceutical Sciences, Kyoto University, Japan
  • 1983 Ph.D., Graduate School of Pharmaceutical Sciences, Kyoto University
  • 1985-1990 Instructor, Department of Pharmacy, Kyoto University Hospital
  • 1990-1993 Lecturer, Department of Pharmacy, Kyoto University Hospital
  • 1991-1992 Research fellow, School of Pharmacy, University of Manchester, U.K.
  • 1993-1998 Associate Professor and Vice Director, Department of Pharmacy, Kobe University Hospital, Japan
  • 1998-2007 Director of Hospital Pharmacy, Keio University Hospital, Japan
  • 1998-present Professor, Department of Clinical Pharmacokinetics and Pharmacodynamics, School of Medicine, Keio University, Japan

2013 2015 McMillin Treasurer 150x200

IATDMCT Treasurer

Gwendolyn McMillin 
University of Utah, ARUP Laboratories, Salt Lake City, UT, USA

[+] View Bio

Gwendolyn A. McMillin received a BA from Grinnell College, in Grinnell, IA, and a PhD in pharmacology and toxicology from the University of Utah, in Salt Lake City, UT. She completed post-doctoral training in Clinical Chemistry through the University of Utah, and is certified by the American Board of Clinical Chemistry (ABCC) in the areas of Clinical Chemistry and Toxicological Chemistry. She is currently an Associate Professor (clinical) of Pathology at the University of Utah, and is a Medical Director at ARUP Laboratories, responsible for the areas of Clinical Toxicology and Pharmacogenomics.

Dr McMillin is actively involved in professional associations. For example, she served as Chair of the TDM/Toxicology Division of the American Association for Clinical Chemistry (AACC), Chair of the Toxicological Chemistry exam and Continuing Education Committee for the American Board of Clinical Chemistry (ABCC), a Member of the Toxicology Resource Committee for the College of American Pathologists (CAP), and is co-Chair of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology's (IATDMCT) 2013 Congress. She was also involved in forming the Personalized Medicine Division of the AACC. Dr McMillin serves as an Editorial Board member for professional journals such as Therapeutic Drug Monitoring and the Journal of Analytical Toxicology, and has published nearly 100 original research manuscripts, review articles, and book chapters. Her research is focused on evaluating and assuring clinical utility of drug testing and pharmacogenomics, funded by several commercial contracts and federal grants.


2013 2015 Brunet DirEd 150x200

Director of Education

Mercè Brunet
University of Barcelona, Barcelona, Spain

[+] View Bio

Mercè Brunet is Professor of Pharmacology and Toxicology at the University of Barcelona; Medical School of Barcelona. She is currently the Head of Pharmacology and Toxicology in the Biologic Diagnostic Center of the Hospital Clínic of Barcelona. She got her Ph.D. in Pharmaceutical Sciences from Barcelona University in 1980.

Mercè Brunet is also currently:

  • Coordinator of the Biomarker Working Group (BWG) of the Scientific Committee of Immunosuppressive Drugs at the IATDMCT.
  • Coordinator of the Master in Translational Medicine (Module1), of the University of Barcelona, School of Medicine.
  • Secretary of the Council of the Sociedad Española de Farmacogenética y Farmacogenómica (SEFF).
  • Secretary of the Council of the Catalan Transplantation Society (CTS).
  • Member of CIBERehd-Networked Biomedical Research Center: Hepatic and Digestive Diseases
  • Member of the International Transplant Society.
  • Member of the European Transplant Society.
  • Member of the Reial Academia de Medicina de Catalunya I Balears.
  • Member of the Editorial Boards of International Journals such us Therapeutic Drug Monitoring (TDM), Trends in Transplantation (TT).

Mercè Brunet's main research interests are focus on treatment personalization, mainly concerning the measurement of biomarkers that may reflect immunosuppressive drugs’ exposure and effect, using pharmacokinetic, pharmacogenetic and pharmacodynamic approaches. Recently most of her work is dedicated to new pharmacokinetic/ pharmacodynamics monitoring strategies for antitumor drugs. She has published over 105 original articles in peer-reviewed international journals and 9 book chapters.


2013 2015 Steenkamp DirEd 150x200

Director of Education

Vanessa Steenkamp
University of Pretoria, Pretoria, South Africa

[+] View Bio

Professor Vanessa Steenkamp obtained her PhD in Clinical Chemistry (Toxicology of traditional herbal remedies). Presently she heads the Phytomedicine Unit, Department of Pharmacology, University of Pretoria, South Africa. She is Past-President of the South African Association of Clinical Biochemistry, Vice-President of the Toxicology Society of South Africa and Secretary-General of the South African Association of Basic & Clinical Pharmacology. Internationally she serves as vice-chair of the IATDMCT Clinical Toxicology committee and participates in the Standards of Laboratory Practice committee. She is a member of the nominating committee of the International Union of Toxicology and serves on the Executive Committee of the IFCC. She strives to better health care provision and with her dedication to the African Federation of Clinical Chemistry, regional federation of the IFCC, of which she is currently President, was inaugurated in 2009.

Vanessa is author/co-author of >70 scientific papers and 3 book chapters. Awards for her research both nationally & internationally, amongst others, include: the prestigious Friedel Sellschop award and Exceptional Young Researcher of the University of Pretoria, the Young Scientist Award from the IATDMCT and AACC. Reviewer for 18 international peer-reviewed journals and on the editorial board of 4 journals. She has lectured worldwide and in 2010 was awarded the IATDMCT travelling lectureship where she presented toxicology lectures in Chile. Vanessa is registered with the Health Professions Council of South Africa as a medical scientist, the South African Council for Natural Scientific Professions (SACNSP) as a Professional Natural Scientist and is a rated scientist with the National Research Foundation. She serves on the Professional Advisory Committee of SACNSP. At the University she serves on various academic and research committees. She has supervised 28 post graduate students to graduation and 10 currently under her supervision.


2013 2015 Wieland DirEd 150x200

Director of Education

Eberhard Wieland
Klinikum-Stuttgart, Stuttgart, Germany

[+] View Bio

Eberhard Wieland is Professor of Clinical Chemistry and Laboratory Medicine . He is Medical Director and head of the Central Institute for Clinical Chemistry and Laboratory Medicine, Klinikum Stuttgart, Germany.

Dr. Wieland received his MD in Biochemistry from the Ruprecht-Karls-University, Heidelberg in 1982. Between 1983 and 1985 he was resident in Internal Medicine and received a training in Medical Microbiology at the University Hospital, Heidelberg.

In 1985 he was awarded a research fellowship by the Volkswagen foundation which he spent between 1985 and 1987 at the Department of Endocrinology and Metabolism of the University of California, San Diego, USA.

From 1987 to 1993 he received his training in Clinical Chemistry and Laboratory Medicine at the Georg-August-University Goettingen. In 1993 he was certified in Clinical Chemistry and became consultant in Laboratory Medicine. In 2000 he was appointed Professor of Clinical Chemistry.

Dr. Wieland became Medical Director and head of the Central Institute of Clinical Chemistry and Laboratory Medicine of Klinikum Stuttgart in 2003. He is teaching Clinical Chemistry and Laboratory Medicine at the Eberhard-Karls-University in Tuebingen.

Dr. Wieland conducts research in pharmacokinetics and pharamacodynamics of immunosupressant drugs. His current research interest is in biomarkers to complement TDM. In addition, he performs funded research on oxidative stress in transplantation medicine and atherosclerosis. Dr. Wieland has contributed over 90 articles for peer reviewed scientific journals and 16 book chapters on the topics TDM, atherosclerosis, oxidative stress and biomarkers. He has presented more than 160 lectures and posters at national and international events. He is an editorial board member of Clinical Biochemistry, Canada; Folia Medica Plovid, Bulgaria; and Journal of Laboratory Medicine, Germany. He is also an active referee for German accreditation bodies.


2013 2015 Beck Councillor 150x200

IATDMCT Councillor

Olof Beck
Karolinska University, Stockholm, Sweden

[+] View Bio

Olof Beck studied chemistry at the Royal Institute of Technology in Stockholm and received his Ph.D. degree in 1982 after working at the Karolinska Institute with studies on biogenic amines using gas chromatography-mass spectrometry methods. After a post-doctoral period at Stanford University and two years in pharmaceutical industry he returned to Karolinska Institute and department of Clinical Pharmacology in 1988. Dr. Beck is at present adjunct professor and laboratory director of the Pharmacology Laboratory comprising TDM, genotyping, clinical and workplace drugs-of-abuse testing, sports doping control and contract analyses in clinical trials. He has been active assessor in laboratory accreditation in the Nordic countries.

Research activities have resulted in about 200 publications. Areas of interest are method developments in pharmacology and toxicology with special focus on mass spectrometry, alcohol biomarkers and toxicology. Most recent work is focused on Internet drugs, breath testing for abused drugs and alcohol biomarker phosphatidylethanol.


2013 2015 Rentsch Councillor 150x200

IATDMCT Councillor

Katharina Rentsch
University Hospital Basel
Basel, Switzerland

[+] View Bio

Katharina M. Rentsch studied pharmacy at the ETH in Zurich, Switzerland and obtained the pharmacist's license in 1988. Thereafter she got a certification as specialist for laboratory medicine FAMH for clinical chemistry and clinical immunology in 1991. In 1996 she finished her PhD thesis on TDM of cytostatic drugs at the ETH Zurich. In 2003 she finished her habilitation in the field of clinical chemistry at the department of chemistry and applied biosciences of the ETH Zurich and in 2007 she habilitated at the medical faculty of the University Zurich, Switzerland. In 2010 she became an adjunct professor at the medical faculty of the University Zurich and in 2012 at the medical faculty of the University Basel. In 2007 she certified as a clinical toxicologist GTFCh.

From 1994 to 2011 Dr Rentsch has been the head of the laboratory for drug analysis and clinical toxicology at the Institute for Clinical Chemistry, University Hospital Zurich. Since December 2011 she is the head of the division of clinical chemistry at the University Hospital Basel, Switzerland. 
Her main research interest is the development of new analytical methodologies for TDM and CT, and their application in different clinical studies as well as the implementation of TDM procedures for new drugs. She is author or co-author of 100 peer-reviewed publications, 8 book chapters and 50 published oral or poster presentations.

Dr Rentsch is currently the head of the Swiss Society of Clinical Chemistry and she is a member of the IATDMCT, the International Association of Forensic Toxicology (TIAFT), the American Association for Clinical Chemistry (AACC), the German Society of Toxicological and Forensic Chemistry (GTFCh), and several other local professional organizations. Since 2006 she is member of the IATDMCT Clinical Toxicology/Drugs of Abuse Committee and has been a member of the scientific board of the Basel Meeting in 2003 and of the local organizing meeting of the Stuttgart Meeting in 2011.


2013 2015 Saint Marcoux Councillor 150x200

IATDMCT Councillor

Franck Saint-Marcoux
Limoges University Hospital, Limoges, France

[+] View Bio

Dr Franck Saint-Marcoux is President of the TDM group of the French Society of Pharmacology and Therapeutics (SFPT) and Chair of the IATDMCT Pharmacometrics Committee. He is currently responsible for the Pharmacology and Pharmacokinetic Unit of the Pharmacology and Toxicology department of the Limoges University Hospital (France), and is a member of the INSERM research unit "Pharmacology of the immunosuppressive drugs in transplantation" directed by Prof. Pierre Marquet.

Dr Franck Saint-Marcoux obtained a Master of Advanced Studies in Pharmacy and a PhD in Pharmacokinetic Modelling in 2004. His research activity is focused on the development of PK tools useful for routine activity of TDM, mainly immunosuppressants, but also antibiotics or anticancer drugs. He is author or co-author of over 40 papers in peer-reviewed international journals.


2013 2015 Seger Councillor 150x200

IATDMCT Councillor

Christoph Seger
University Hospital Innsbruck, Innsbruck, Austria

[+] View Bio

Christoph Seger studied Chemistry and Biochemistry at the University of Vienna, Austria (PhD 2001, University of Vienna). After focusing on NMR based structure elucidation of Natural Products and peptides (Max Planck Institute for Biochemistry, Martinsried, Germany) for several years he took up a lecturer position at the Institute of Pharmacy at the University of Graz, Austria, followed by Post-Doc appointment at the Institute of Pharmacy at the University of Innsbruck, Austria. He obtained his venia legendi (Habilitation) at the University of Innsbruck in 2008 for his research focus on Pharmaceutical Analysis.

Since 2005 he is technical head of the ISO 15189 accredited Mass Spectrometry and Chromatography laboratory at the Central Institute of Medicinal and Chemical Laboratory Diagnostics (ZIMCL) / University Hospital Innsbruck, Austria which focuses on TDM and endocrinology testing. 
Besides serving as council member for the IATDMCT, where he is also ISD scientific committee member, he is a board member of the Austrian Society for Analytical Chemistry (ASAC) and the Austrian Society of Laboratory Medicine and Clinical Chemistry (ÖGLMKC). He serves as review team I / II member for the Joint Committee for Traceability in Laboratory Medicine (JCTLM) Working Group and has been appointed as PT scheme leader for drugs of the Austrian Society for Quality Assurance and Standardization of Medical-Diagnostics (ÖQUASTA). 

He is involved in academic teaching at the University of Innsbruck, the Medical University Innsbruck and the UMIT. In addition he has supervised more than a dozen BA, MS, and PhD theses projects. His publication record currently holds 60+ peer reviewed papers and reviews, about 50 conference abstracts in peer reviewed journals, 40 invited lectures and more than 130 other conference contributions (lectures, poster presentations).

Council Members 2011-2013

IATDMCT Council 2011-2013

Position Name Organization
Location
President Pierre Marquet University Hospital Limoges
Limoges, France
President-Elect Pierre Wallemacq University Hospital St. Luc
Brussels, Belgium
Past President Alexander (Sander) A. Vinks Cincinnati Children's Hospital and Medical Center
Cincinnati, OH, USA
Secretary Donald LeGatt University of Alberta Hospital
Edmonton, AB, Canada
Treasurer Loralie J. Langman Mayo Clinic
Rochester, MN, USA
Director of Education Tuen van Gelder Erasmus Medical Center
Rotterdam, The Netherlands
Director of Education Paul Taylor Princess Alexandra Hospital
Brisbane, QLD, Australia
Director of Education Eberhard Wieland Klinikum Stuttgart
Stuttgart, Germany
Councilor Olof Beck Karolinska Institutet
Stockholm, Sweden
Councilor Frank T. Peters University Hospital Jena
Jena, Germany
Councilor Katharina Rentsch University Hospital Basel
Basel, Switzerland
Councilor Benedetta Sallustio The Queen Elizabeth Hospital
Woodville, SA, Australia

Council Members 2009-2011

IATDMCT Council 2009-2011

Position Name Organization
Location
President Alexander (Sander) A. Vinks Cincinnati Children's Hospital and Medical Center
Cincinnati, OH, USA
President-Elect Pierre Marquet University Hospital Limoges
Limoges, France
Past President Hans H. Maurer Saarland University
Homburg/Saar, Germany
Secretary Donald LeGatt University of Alberta Hospital
Edmonton, AB, Canada
Treasurer Loralie J. Langman Mayo Clinic
Rochester, MN, USA
Director of Education Tuen van Gelder Erasmus Medical Center
Rotterdam, The Netherlands
Director of Education Vanessa Steenkamp University of Pretoria
Pretoria, South Africa
Director of Education Pierre Wallemacq University Hospital St. Luc
Brussels, Belgium
Councilor Mercè Brunet Hospital Clinic of Barcelona
Barcelona, Spain
Councilor William Clarke Johns Hopkins Medicine
Baltimore, MD, USA
Councilor Frank T. Peters Friedrich Schiller University of Jena
Jena, Germany
Councilor Benedetta Sallustio The Queen Elizabeth Hospital
Woodville, SA, Australia

Council Members 2007-2009

IATDMCT Council 2007-2009

Position Name Organization
Location
President Hans H. Maurer Saarland University
Homburg, Germany
President-Elect Alexander (Sander) A. Vinks Cincinnati Children's Hospital and Medical Center
Cincinnati, OH, USA
Past President David W. Holt St. George's University of London
London, UK
Secretary Pierre Marquet University Hospital Limoges
Limoges, France
Treasurer Victor W. Armstrong Georg-August-Universität Göttingen
Göttingen, Germany
Director of Education Marilyn Huestis Biomedical Research Center (NIDA/NIH)
Baltimore, MD, USA
Director of Education Atholl Johnston Barts / London Queen Mary's University
London, UK
Director of Education Sandra Solari Catholic University of Chile
Santiago, Chile
Councilor Christine Collier Kingston General Hospital / Queen's University
Kingston, ON, Canada
Councilor Loralie J. Langman Mayo Clinic
Rochester, MN, USA
Councilor Tuen van Gelder Erasmus Medical Center
Rotterdam, The Netherlands
Councilor Pierre Wallemacq University Hospital St. Luc
Brussels, Belgium

Council Members 2005-2007

IATDMCT Council 2005-2007

Position Name Organization
Location
President David W. Holt St. George's University of London
London, UK
President-Elect Hans H. Maurer University of Saarland
Homburg , Germany
Past President Steven J. Soldin Children's National Medical Center /
George Washington University
Washington, DC, USA
Secretary Alexander (Sander) A. Vinks Cincinnati Children's Hopital and Medical Center
Cincinnati, OH, USA
Treasurer Victor W. Armstrong Georg-August-Universität Göttingen
Göttingen, Germany
Director of Education Uwe Christians University of Colorado Health Sciences Center
Denver, CO, USA
Director of Education Atholl Johnston Barts / London Queen Mary's University
London, UK
Director of Education Sandra Solari Catholic University of Chile
Santiago, Chile
Councilor Christine Collier Kingston General Hospital / Queen's University
Kingston, ON, Canada
Councilor Claire George City Hospital
Birmingham W. Midlands, UK
Councilor Paul J. Taylor Princess Alexandra Hospital
Brisbane, QLD, Australia
Councilor Li Wang Peking University First Hospital
Beijing, China

Council Members 2003-2005

IATDMCT Council 2003-2005

Position Name Organization
Location
President Steven J. Soldin Children's National Medical Center /
George Washington University
Washington, DC, USA
President-Elect David W. Holt St. George's University of London
London, UK
Past President Albert D. Fraser Queen Elizabeth II Health Sciences Centre /
Capital Health
Halifax, NS, Canada
Secretary Alexander (Sander) A. Vinks Cincinnati Children's Hopital and Medical Center
Cincinnati, OH, USA
Treasurer Raymond G. Morris The Queen Elizabeth Hospital
Woodville, SA, Australia
Director of Education Uwe Christians University of Colorado Health Sciences Center
Denver, CO, USA
Director of Education Donald LeGatt University of Alberta Hospitals
Edmonton, AB, Canada
Director of Education Hans H. Maurer University of Saarland
Homburg, Germany
Councilor Victor W. Armstrong Georg-August-Universität Göttingen
Göttingen, Germany
Councilor Paul J. Taylor Princess Alexandra Hospital
Brisbane, QLD, Australia
Councilor Li Wang Peking University First Hospital
Beijing, China
Councilor John F. Wilson Wales College of Medicine
Cardiff, Wales, UK

Council Members 2001-2003

IATDMCT Council 2001-2003

Position Name Organization
Location
President Albert D. Fraser Queen Elizabeth II Health Sciences Centre
Halifax, NS, Canada
President-Elect Steven J. Soldin Children's National Medical Center /
George Washington University
Washington, DC, USA
Past President Leslie (Les) M. Shaw Hospital of the University of Pennsylvania
Philadelphia, PA, USA
Secretary Kimberly L. Napoli University of Texas Medical School at Houston
Houston, TX, USA
Treasurer Raymond G. Morris The Queen Elizabeth Hospital
Woodville, SA, Australia
Director of Education Donald LeGatt University of Alberta Hospitals
Edmonton, AB, Canada
Director of Education Hans H. Maurer University of Saarland
Homburg, Germany
Director of Education Susan Tett The University of Queensland
Brisbane, QLD, Australia
Councilor Victor W. Armstrong Georg-August-Universität Göttingen
Göttingen, Germany
Councilor Leendert J. Mostert Deltalab
Poortugaal, The Netherlands
Councilor Michael Stewart University of the Witwatersrand Medical School
Parktown, South Africa
Councilor John F. Wilson University of Wales
Cardiff, Wales, UK

Council Members 1999-2001

IATDMCT Council 1999-2001

Position Name Organization
Location
President Leslie (Les) M. Shaw Hospital of the University of Pennsylvania
Philadelphia, PA, USA
President-Elect Albert D. Fraser Queen Elizabeth II Health Sciences Centre
Halifax, NS, Canada
Past President Michael Oellerich Georg-August-Universität Göttingen
Göttingen, Germany
Secretary Kimberly L. Napoli University of Texas Medical School at Houston
Houston, TX, USA
Treasurer Tai C. Kwong University of Rochester Medical Center
Rochester, NY, USA
Director of Education David W. Holt St. George's Hospital Medical School
London, UK
Director of Education Raymond G. Morris The Queen Elizabeth Hospital
Woodville, SA, Australia
Director of Education Alexander (Sander) A. Vinks The University of Cincinnati College of Medicine
Cincinatti, OH, USA
Councilor Ken Ilett University of Western Australia
Nedlands, WA, Australia
Councilor Donald LeGatt University of Alberta Hospitals
Edmonton, AB, Canada
Councilor Michael Stewart University of the Witwatersrand Medical School
Parktown, South Africa
Councilor Alison Thomson University of Glasgow / Western Infirmary
Glasgow, Scotland, UK

Council Members 1997-1999

IATDMCT Council 1997-1999

Position Name Organization
Location
President Michael Oellerich Georg-August-Universität Göttingen
Göttingen, Germany
President-Elect Leslie (Les) M. Shaw Hospital of the University of Pennsylvania
Philadelphia, PA, USA
Past President Philip Walson Children's Hospital Medical Center
Cincinnati, OH, USA
Secretary Albert D. Fraser Queen Elizabeth II Health Sciences Centre
Halifax, NS, Canada
Treasurer Tai C. Kwong University of Rochester Medical Center
Rochester, NY, USA
Director of Education Victor W. Armstrong Georg-August-Universität Göttingen
Göttingen, Germany
Director of Education David W. Holt St. George's Hospital Medical School
London, UK
Director of Education Kimberly L. Napoli University of Texas Medical School
Houston, TX, USA
Councilor Raymond G. Morris The Queen Elizabeth Hospital
Woodville, SA, Australia
Councilor Philip N. Patsalos UCL Institute of Neurology
London, UK
Councilor Dobrin A. Svinarov Medical University of Sofia
Sofia, Bulgaria
Councilor Steven H.Y. Wong Medical College of Wisconsin
Milwaukee, WI, USA

Council Members 1995-1997

IATDMCT Council 1995-1997

Position Name Organization
Location
President Philip Walson University of Cincinnati
Children's Hospital Medical Center
Cincinnati, OH, USA
President-Elect Michael Oellerich Georg-August-Universität Göttingen
Göttingen, Germany
Past President Ian D. Watson University Hospital Aintree
Liverpool, UK
Secretary Albert D. Fraser Queen Elizabeth II Health Sciences Centre
Halifax, NS, Canada
Treasurer Leslie (Les) M. Shaw Hospital of the University of Pennsylvania
Philadelphia, PA, USA
Director of Education Julia Potter Royal Brisbane Hospital
Herston, QLD, Australia
Director of Education Juliette Säwe Karolinska Institute / Huddinge University Hospital
Huddinge, Sweden
Director of Education Steven H.Y. Wong Medical College of Wisconsin
Milwaukee, WI, USA
Councilor David W. Holt St. George's Hospital Medical School
London, UK
Councilor Takashi Mimaki Gifu University
Gifu City, Japan
Councilor Raymond G. Morris The Queen Elizabeth Hospital
Woodville, SA, Australia
Councilor Kimberly L. Napoli University of Texas Medical School
Houston, TX, USA

Council Members 1993-1995

IATDMCT Council 1993-1995

Position Name Organization
Location
President Ian D. Watson University Hospital Aintree
Liverpool, UK
President-Elect Philip Walson University of Cincinnati
Children's Hospital Medical Center
Cincinnati, OH, USA
Past President Steven H.Y. Wong Medical College of Wisconsin
Milwaukee, WI, USA
Secretary Randall Yatscoff Isotechnika Inc.
Edmonton, AB, Canada
Treasurer Roger Boeckx Abbott Laboratories
Libertyville, IL, USA
Director of Education Petrie Rainey Yale School of Medicine
New Haven, CT, USA
Director of Education Leslie (Les) M. Shaw Hospital of the University of Pennsylvania
Philadelphia, PA, USA
Director of Education Folke Sjӧqvist Karolinska Institutet / Huddinge University Hospital
Huddinge, Sweden
Councilor Halina Matsumoto The Medical University School of Warsaw
Warsaw, Poland
Councilor Julia Potter Royal Brisbane Hospital
Herston, QLD, Australia
Councilor Kazuhiko Tanaka Osaka University of Pharmaceutical Sciences
Osaka, Japan
Councilor Ester Zylber-Katz Hadassah University Hospital
Jerusalem, Israel

Council Members 1991-1993

IATDMCT Council 1991-1993

Position Name Organization
Location
President Steven H.Y. Wong Medical College of Wisconsin
Milwaukee, WI, USA
President-Elect Ian D. Watson University Hospital Aintree
Liverpool, UK
Past President n/a  
Secretary Philip Walson University of Cincinnati
Children's Hospital Medical Center
Cincinnati, OH, USA
Treasurer Roger Boeckx Abbott Laboratories
Libertyville, IL, USA
Director of Education Petrie Rainey Yale School of Medicine
New Haven, CT, USA
Director of Education Folke Sjӧqvist Karolinska Institutet / Huddinge University Hospital
Huddinge, Sweden
Director of Education n/a  
Councilor Anthony Fell  
Councilor Halina Matsumoto The Medical University School of Warsaw
Warsaw, Poland
Councilor John Miners Flinders Medical Center
Bedford Park, SA, Australia
Councilor Kazuhiko Tanaka Osaka University of Pharmaceutical Sciences
Osaka, Japan